✦ LIBER ✦

Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia — a phase II study

✍ Scribed by S. H. Lim; A. C. Newland; S. Kelsey; A. Bell; E. Offerman; C. Rist; D. Gozzard; D. Bareford; M. P. Smith; A. H. Goldstone

Book ID: 105295443
Publisher: Springer-Verlag
Year: 1992
Tongue: English
Weight: 698 KB
Volume: 34
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf01741555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continuous infusion of intermediate-dose

Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: A prospective, multicenter phase II study

✍ Hawk Kim; Jae-Hoo Park; Je-Hwan Lee; Jung-Hee Lee; Young-Don Joo; Won-Sik Lee; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 3 views

Phase II study of 2-chlorodeoxyadenosine

Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a Paediatric Oncology Group study

✍ Stanley Chaleff; Craig A. Hurwitz; Myron Chang; Gary Dahl; Todd A. Alonzo; Howar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Daily alternating administration of high

Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study

✍ Lothar Bergmann; Klaus Fenchel; Eckhart Weidmann; Hans-Martin Enzinger; Bernhard 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 852 KB

Continuous infusion of high-dose 5-fluor

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A multicenter phase II study

✍ Cornelis J. A. Punt; Jos Th. M. Burghouts; Jelle J. Croles; Peter A. van Liessum 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

A phase II trial of high-dose imatinib m

A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial

✍ Patrice Chevallier; Mathilde Hunault-Berger; Fabrice Larosa; Charles Dauriac; Ri 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Temsirolimus, an mTOR inhibitor, in comb

Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)

✍ Sergio Amadori; Roberto Stasi; Alberto M. Martelli; Adriano Venditti; Giovanna M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB